Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1985-10-21
|
pubmed:abstractText |
The time change of laboratory variables in cirrhosis was studied by analysis of data from 488 patients with cirrhosis included in a controlled clinical trial of long-term prednisone vs. placebo. In the placebo group, a marked regression towards normal was seen within 3 months of entry into the trial (increase in serum albumin, acetylcholinesterase, cholesterol, hemoglobin and decrease in erythrocyte sedimentation rate). The subsequent course did not show a clear pattern, except for a slight increase in serum bilirubin and decrease in albumin. When studied in relation to the time of death in patients dying from a "hepatic" cause, marked increase in bilirubin and decrease in prothrombin index, albumin and cholesterol were seen in the year prior to death with little change before that time. In the prednisone group, a more marked decrease in bilirubin, SGOT, alkaline phosphatase, gamma-globulin, sulfobromophthalein retention, erythrocyte sedimentation rate and increase in leukocytes, prothrombin index and cholesterol were seen during the first 3 months. In relation to time of death from a "hepatic" cause, similar changes were seen as in the placebo group except that alkaline phosphatase increased and cholesterol did not decrease. A beneficial effect of prednisone on survival, as expressed by a previously developed therapeutic index, was associated with decrease in SGOT, alkaline phosphatase and gamma-globulin within the first 3 months. An increase in SGOT during prednisone seemed to be associated with harmful effects of therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholinesterase,
http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Bilirubin,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobins,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin,
http://linkedlifedata.com/resource/pubmed/chemical/gamma-Globulins
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0270-9139
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
843-53
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2411649-Acetylcholinesterase,
pubmed-meshheading:2411649-Alkaline Phosphatase,
pubmed-meshheading:2411649-Bilirubin,
pubmed-meshheading:2411649-Cholesterol,
pubmed-meshheading:2411649-Hemoglobins,
pubmed-meshheading:2411649-Humans,
pubmed-meshheading:2411649-Liver Cirrhosis,
pubmed-meshheading:2411649-Prednisone,
pubmed-meshheading:2411649-Prognosis,
pubmed-meshheading:2411649-Prospective Studies,
pubmed-meshheading:2411649-Prothrombin Time,
pubmed-meshheading:2411649-Reference Values,
pubmed-meshheading:2411649-Serum Albumin,
pubmed-meshheading:2411649-Time,
pubmed-meshheading:2411649-gamma-Globulins
|
pubmed:articleTitle |
Changes of laboratory variables with time in cirrhosis: prognostic and therapeutic significance.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|